Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Continuity-Bioscience

More Like This

PR Newswire associated0

Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study

PR Newswire associated0

Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors

PR Newswire associated0

Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer

PR Newswire associated0

Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

PR Newswire associated0

Continuity Biosciences Invests in PinPrint, Inc., Expanding into Aesthetic and Cosmetic Drug Delivery

PR Newswire associated0

Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors

PR Newswire associated0

Fifteen Years Alongside Europe's Drug Discovery Teams: Viva Biotech Strengthens Continuity from Discovery to Development and Manufacturing

PR Newswire associated0

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing